Latest Press Releases

Health News Posted on Monday, December 30, 2024

Press Releases »

Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726

PR Newswire SUZHOU, China, Dec. 30, 2024 SUZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. ...

Read More

Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration

PR Newswire SEOUL, South Korea, Dec. 30, 2024 SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a ...

Read More

IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors

PR Newswire SOUTH SAN FRANCISCO, Calif. and SHANGHAI, Dec. 29, 2024 SOUTH SAN FRANCISCO, Calif. and SHANGHAI, Dec. 29, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the ...

Read More

Colossal Raises More Than $6.9 Million to Benefit the National Breast Cancer Foundation Through Its 2024 Fab Over 40 Competition

PR Newswire PHOENIX, Dec. 27, 2024 Dr. April Black has been crowned champion and will be featured on the cover of NewBeauty magazine PHOENIX, Dec. 27, 2024 /PRNewswire/ -- Colossal, the nation's leading professional fundraiser, announces ...

Read More

NAVIGANTIS VASCO™ Robotic Platform Used with First Patients Enrolled in Neurovascular Study

PR Newswire MIAMI, Dec. 27, 2024 MIAMI, Dec. 27, 2024 /PRNewswire/ -- Navigantis Inc. announced today the first successful neurovascular clinical cases performed with its VASCO interventional robotic platform for patients suffering from ...

Read More

AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B

PR Newswire SAN FRANCISCO, Dec. 26, 2024 SAN FRANCISCO, Dec. 26, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

Read More

Watercrest Buena Vista Decks the Halls to Benefit Wreaths Across America

PR Newswire VERO BEACH, Fla., Dec. 26, 2024 VERO BEACH, Fla., Dec. 26, 2024 /PRNewswire/ -- 'Tis the season for giving and the residents and associates of Watercrest Buena Vista Senior Living warmly embraced the sentiment with a festive ...

Read More

FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products

PR Newswire SILVER SPRING, Md., Dec. 26, 2024 SILVER SPRING, Md., Dec. 26, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration (FDA) announced a proposed rule to establish and require standardized testing methods to detect and ...

Read More

Doctor Becomes First to Offer Innovative Glaucoma Treatment in Harford County

PR Newswire BEL AIR, Md., Dec. 26, 2024 BEL AIR, Md., Dec. 26, 2024 /PRNewswire/ -- Dr. Lisa Feulner, MD, PhD, of Advanced Eye Care & Aesthetics, a managed ophthalmology practice of Vision Innovation Partners (VIP), is bringing cutting-edge ...

Read More

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment

PR Newswire VANCOUVER, BC, Dec. 26, 2024 USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 26, 2024 /PRNewswire/ -- USA News Group News Commentary – Immunotherapy is transforming oncology by ...

Read More

Steps to Address Your Hearing Health in 2025

PR Newswire FARMINGTON HILLS, Mich., Dec. 26, 2024 Make Hearing Health Your New YEAR'S Resolution, Recommends the International Hearing Society FARMINGTON HILLS, Mich., Dec. 26, 2024 /PRNewswire/ -- For many people, the start of a new ...

Read More

HealthyBaby Pledges 750,000 Diapers to Families in Need

PR Newswire NEW YORK, Dec. 26, 2024 Beloved Babycare Brand Has Partnered with Robin Hood and Baby2Baby to Help New Parents Nationwide NEW YORK, Dec. 26, 2024 /PRNewswire/ -- Today, HealthyBaby, the pioneering leader of the safest baby ...

Read More

Towards Better Hygiene Standards: Detecting Fecal Contamination of Water Using Viral DNA

PR Newswire DAEJEON, South Korea, Dec. 26, 2024 Scientists develop a new method to detect fecal contamination of water, paving the way towards healthier living environments globally DAEJEON, South Korea, Dec. 26, 2024 /PRNewswire/ -- The ...

Read More

Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment

PR Newswire NEW YORK, Dec. 26, 2024 Hoth Therapeutics Enters Exclusive Patent License Agreement with VA and Emory University Hoth Also Expands Its' Intellectual Property to Further Its' Market Opportunity for HT-001 NEW YORK, Dec. ...

Read More

Researchers from Korea University Explore How Ascorbic acid and FGF4 Revolutionize Regenerative Medicine

PR Newswire SEOUL, South Korea, Dec. 26, 2024 Korean scientists discover a groundbreaking method to transform ordinary fibroblasts into mature cardiomyocytes SEOUL, South Korea, Dec. 26, 2024 /PRNewswire/ -- Researchers at Korea ...

Read More

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

PR Newswire TEL AVIV, Israel, Dec. 26, 2024 TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human ...

Read More

Casect Launches AI-Enhanced Case Log Platform for Surgeons

PR Newswire SHERIDAN, Wyo., Dec 25, 2024 SHERIDAN, Wyo., Dec 25, 2024 /PRNewswire/ -- Casect, LLC, a medical education technology company, announces the launch of an innovative platform to revolutionize how surgeons and medical professionals ...

Read More

Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting

PR Newswire JINAN, China, Dec. 25, 2024 JINAN, China, Dec. 25, 2024 /PRNewswire/ -- During the 66th Annual Meeting of the American Society of Hematology (ASH) held in San Diego from December 7 to 10, preliminary results from the first human ...

Read More

Children's Colorado Signs Agreement with TriWest to Preserve Access to Pediatric Care for Military Families

PR Newswire AURORA, Colo., Dec. 24, 2024 AURORA, Colo., Dec. 24, 2024 /PRNewswire/ -- Over the last several days, Children's Hospital Colorado (Children's Colorado) has negotiated a new agreement with TriWest Healthcare Alliance (TriWest) to ...

Read More

Israeli Doctors from Save a Child's Heart Deliver Christmas Miracles to Zambian Children

PR Newswire ROCKVILLE, Md., Dec. 24, 2024 ROCKVILLE, Md., Dec. 24, 2024 /PRNewswire/ -- In the spirit of the Christmas season, a team of Israeli doctors recently completed a humanitarian mission to Zambia, bringing hope and healing to 25 ...

Read More

Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia

PR Newswire GUANGZHOU, China, Dec. 24, 2024 GUANGZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of ...

Read More

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS

PR Newswire NANTONG and SUZHOU, China, Dec. 24, 2024 NANTONG and SUZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today ...

Read More

Empowering Youth: Students Learn About Cancer Detection, Treatment, and Hope

PR Newswire BENGALURU, India, Dec. 24, 2024 Manipal Hospital Old Airport Road Raises Cancer Awareness with 'Breaking Barriers, Building Awareness' BENGALURU, India, Dec. 24, 2024 /PRNewswire/ -- For many youngsters, cancer remains an ...

Read More

Truckloads of Cheer: Truck Master Warranty Donates Toy Trucks to Children's Hospitals for the Holidays

PR Newswire AKRON, Ohio and KANSAS CITY, Kan., Dec. 23, 2024 AKRON, Ohio and KANSAS CITY, Kan., Dec. 23, 2024 /PRNewswire/ -- Truck Master Warranty, a leader in commercial medium and heavy-duty truck protection plans, donated hundreds of toy ...

Read More

Statement from the Minister of Mental Health and Addictions and Associate Minister of Health on the toxic illegal drug and overdose crisis

Canada NewsWire OTTAWA, ON, Dec. 23, 2024 OTTAWA, ON, Dec. 23, 2024 /CNW/ - Canada is facing a tragic public health crisis that has left no community untouched. The overdose crisis is driven by a dangerous, illegal toxic drug supply. The ...

Read More

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

PR Newswire SILVER SPRING, Md., Dec. 23, 2024 SILVER SPRING, Md., Dec. 23, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a ...

Read More

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

PR Newswire VANCOUVER, BC, Dec. 23, 2024 Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 23, 2024 /PRNewswire/ -- USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the ...

Read More

Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis

PR Newswire CHENGDU, China, Dec. 23, 2024 CHENGDU, China, Dec. 23, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the ...

Read More

Nearly 50% of Young People Resolve to Quit Nicotine in 2025

PR Newswire WASHINGTON, Dec. 23, 2024 EX Program by Truth Initiative Offers a Proven Path to Success WASHINGTON, Dec. 23, 2024 /PRNewswire/ -- Almost half (48%) of young people aged 18-24 are making quitting nicotine a priority for their ...

Read More

Sumitomo Pharma America Announces U.S. FDA Approval of GEMTESA® (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia

PR Newswire MARLBOROUGH, Mass., Dec. 23, 2024 – GEMTESA® is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH – MARLBOROUGH, Mass., Dec. 23, 2024 ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.